Phibro Animal Health (NASDAQ:PAHC) Stock Price Down 6.5%

Phibro Animal Health Co. (NASDAQ:PAHC) traded down 6.5% on Wednesday . The stock traded as low as $12.73 and last traded at $12.73. 55,607 shares were traded during mid-day trading, a decline of 61% from the average session volume of 140,861 shares. The stock had previously closed at $13.61.

Analysts Set New Price Targets

Separately, StockNews.com upgraded shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a report on Tuesday, April 9th.

Phibro Animal Health Price Performance

The company’s fifty day moving average is $12.80 and its two-hundred day moving average is $11.76. The company has a quick ratio of 1.60, a current ratio of 3.12 and a debt-to-equity ratio of 1.66. The firm has a market capitalization of $508.72 million, a price-to-earnings ratio of 36.11, a price-to-earnings-growth ratio of 4.83 and a beta of 0.75.

Phibro Animal Health (NASDAQ:PAHC) last posted its earnings results on Wednesday, February 7th. The company reported $0.33 earnings per share for the quarter, topping the consensus estimate of $0.27 by $0.06. The company had revenue of $249.90 million for the quarter, compared to analyst estimates of $242.91 million. Phibro Animal Health had a net margin of 1.51% and a return on equity of 16.67%. Equities research analysts anticipate that Phibro Animal Health Co. will post 1.12 earnings per share for the current fiscal year.

Phibro Animal Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Wednesday, March 6th were issued a $0.12 dividend. The ex-dividend date of this dividend was Tuesday, March 5th. This represents a $0.48 annualized dividend and a yield of 3.82%. Phibro Animal Health’s dividend payout ratio (DPR) is presently 133.33%.

Institutional Investors Weigh In On Phibro Animal Health

A number of hedge funds and other institutional investors have recently made changes to their positions in PAHC. China Universal Asset Management Co. Ltd. grew its position in Phibro Animal Health by 358.6% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 2,357 shares of the company’s stock valued at $27,000 after purchasing an additional 1,843 shares in the last quarter. Quest Partners LLC bought a new position in shares of Phibro Animal Health in the 4th quarter valued at about $56,000. Tower Research Capital LLC TRC grew its position in shares of Phibro Animal Health by 549.8% in the 4th quarter. Tower Research Capital LLC TRC now owns 8,200 shares of the company’s stock valued at $95,000 after acquiring an additional 6,938 shares during the period. Nisa Investment Advisors LLC grew its position in shares of Phibro Animal Health by 19.2% in the 4th quarter. Nisa Investment Advisors LLC now owns 8,500 shares of the company’s stock valued at $98,000 after acquiring an additional 1,370 shares during the period. Finally, SG Americas Securities LLC bought a new position in shares of Phibro Animal Health in the 3rd quarter valued at about $126,000. 99.34% of the stock is currently owned by institutional investors and hedge funds.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.